MIR924HG

Across TCGA pan-cancer cohorts, MIR924HG RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MIR924HG data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MIR924HG RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR924HG expression acts as an unfavorable survival marker, although some lineages such as SKCM and OV show a favorable association.

KICH, MESO, and CHOL are the cancer types where MIR924HG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	III,IV	0.252	0.951	<.001	97	view →
MESO	OS	Median	All	0.247	0.517	<.001	76	view →
CHOL	DFS	Median	II,III,IV	0.115	0.630	<.001	66	view →
ACC	DFS	Median	II,III,IV	0.236	0.609	.001	56	view →
LGG	OS	Median	All	0.318	0.575	<.001	54	view →
ESCA	DFS	Median	All	0.379	0.599	.001	48	view →
UVM	OS	Tertile	All	0.477	0.910	<.001	45	view →
LIHC	OS	Median	All	0.614	0.784	.001	43	view →
UCEC	DFS	Quartile	All	0.621	0.828	.003	40	view →
SKCM	OS	Quartile	All	0.838	0.706	<.001	38	view →
LUAD	OS	Median	All	0.601	0.765	<.001	33	view →
OV	OS	Quartile	III,IV	0.884	0.785	.002	26	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MIR924HG–KICH (DFS)

Open the KICH breakdown →